Thalidomide

Treatment options for transplant-ineligble myeloma patients: the promise of combination therapies

Day 2 wrap-up: pushing myeloma boundaries

Novel targets in 2022

The evolving treatment landscape in multiple myeloma & ongoing research

Treatment approaches for transplant-eligible and transplant-ineligbile myeloma patients

Myeloma highlights: UK perspective

Assessing post-autoSCT maintenance in patients with myeloma with or without extramedullary disease

Treating multiple myeloma in the UK

Optimal treatment strategies for multiple myeloma

MRD highlights from the IMW meeting

Unmet needs for polycythemia vera treatment

Real-world data on upfront subcutaneous bortezomib-containing regimens for newly diagnosed myeloma

Cassiopeia: analysis of daratumumab maintenance for myeloma

AGMT MM 02: outcomes and time to best response in myeloma

Treating elderly myeloma: frailty scoring and latest trial data

A new era of treatment for multiple myeloma